Moderna expects the Food and Drug Administration to make an approval decision on its next-generation Covid vaccine in late May. The company is also working to expand its RSV vaccine to people younger ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

It has been almost five years since the COVID-19 pandemic happened and yet, costly irregularities, shortcomings and missteps surrounding the Duterte era COVID-19 pandemic response continue to rear ...

It has been almost five years since the COVID-19 pandemic happened and close to two years since President Marcos lifted the ...

Kennedy, who has faced opposition from health groups and Democrats, has long sown doubts about the safety and efficacy of ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

RNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman ...

High vaccine wastage and low vaccination and booster rates marred the government’s P74.68-million COVID-19 National ...

Fla., praised news that President Donald Trump will reinstate service members expelled for refusing to take the COVID-19 ...

In that vein, let's learn about the three most important things you should know if you're going to consider investing in ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain ...